Press Release

Graeme Thickins

https://www.prweb.com/releases/silktech_biopharmaceuticals_ind_submission_cleared_by_fda_phase_2_clinical_trial_initiated_for_patients_with_dry_eye_disease/prweb16242674.htm
Like this project

Posted Mar 30, 2021

Naming/Branding/Content
Naming/Branding/Content
Startup Website
Startup Website
Ghostwritten article
Ghostwritten article

Join 50k+ companies and 1M+ independents

Contra Logo

© 2025 Contra.Work Inc